Last updated 2026-06-18
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
science-driven investment firm dedicated to advancing disruptive medicines.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is TCG X's investment thesis?
- TCG X is a science-driven investment firm dedicated to advancing disruptive medicines.
- Which sectors does TCG X primarily invest in?
- TCG X focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and investment rounds concentrated there.
- What is TCG X's typical investment range?
- TCG X's investment range is between $200M and $200M.
- Can you name a notable portfolio company for TCG X?
- Upstream Bio, a company founded in 2021 that develops monoclonal antibody drugs for asthma patients, is a notable portfolio company for TCG X.
- Has TCG X participated in any B Round investments recently?
- Yes, TCG X participated in a B Round investment in June 2023.
- When did TCG X make its most recent investment?
- TCG X made an investment in June 2023.
- What was TCG X's first recorded investment in a new portfolio company?
- TCG X made its first recorded investment in a new portfolio company in June 2022.
- What is the business model of TCG X's portfolio company, Upstream Bio?
- Upstream Bio operates on a B2B business model.